سعر جرين 250 وحدة دولية فيال 2023

Green-VIII coagulation factor VIII 250 IU vial for injection by Green Cross (Korea), imported by EIMC; specialist haemophilia A replacement therapy.

• Hypersensitivity to the active substance or any excipient.General active-ingredient information · AEMPS CIMA (Spanish Agency of Medicines and Medical Devices)

• Allergic-type hypersensitivity reactions are possible (hives, generalised urticaria, chest tightness, wheezing, hypotension, anaphylaxis); stop administration immediately if they occur.General active-ingredient information · AEMPS CIMA (Spanish Agency of Medicines and Medical Devices)
• Neutralising antibodies (inhibitors) to factor VIII are a known complication in haemophilia A; the risk is highest in the first 50 exposure days and persists lifelong.General active-ingredient information · AEMPS CIMA (Spanish Agency of Medicines and Medical Devices)
• Treatment should be supervised by a physician experienced in haemophilia; record the product name and batch number for traceability.General active-ingredient information · AEMPS CIMA (Spanish Agency of Medicines and Medical Devices)

• No animal reproduction studies; because haemophilia A is rare in women there is no clinical experience in pregnancy; use only if clearly indicated.General active-ingredient information · AEMPS CIMA (Spanish Agency of Medicines and Medical Devices)
• No clinical experience during breastfeeding; use only if clearly indicated.General active-ingredient information · AEMPS CIMA (Spanish Agency of Medicines and Medical Devices)

• Monitor factor VIII plasma levels to guide dose and infusion frequency (precise monitoring is essential in major surgery) and monitor patients for development of factor VIII inhibitors.General active-ingredient information · AEMPS CIMA (Spanish Agency of Medicines and Medical Devices)

• Coagulation factor VIII: Activated factor VIII acts as a cofactor for activated factor IX, accelerating conversion of factor X to Xa and enabling clot formation.